ArticleEndocrine2026
Comprehensive evaluation of TIR 3B thyroid nodules: Clinical, Ultrasonographical and Cytological features for prediction of malignancy.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThyroid nodules are common clinical findings, with a subset requiring evaluation for malignancy. TIR 3B nodules, classified as indeterminate with high risk, present a diagnostic challenge. This study aims to identify clinical, ultrasonographic, and cytological features predictive of malignancy in TIR 3B thyroid nodules.
methodsWe retrospectively analyzed 175 patients with TIR 3B nodules who underwent surgery, evaluating their clinical, ultrasound, and cytological characteristics.
resultsThe malignancy rate was 43.4%, with papillary thyroid carcinoma being the most prevalent. Multivariable analysis identified solid hypoechoic nodules, irregular margins, nuclear grooves, and micro- and macrocalcifications as independent predictors of malignancy. Based on these features, we developed a predictive nomogram model with an area under the curve (AUC) of 0.790, demonstrating good diagnostic performance. The model identified a malignancy risk cut-off score of 8, with high specificity (94%) for distinguishing benign from malignant nodules.
conclusionsThis study highlighted several findings regarding malignancy risk and identified ultrasonographic and cytological features associated with malignant outcomes to help determine which patients should be candidates for surgery. The proposed predictive model could be a valuable clinical tool and may facilitate more personalized treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.